Gsk (GSK) Cash & Equivalents (2009 - 2026)
Gsk (GSK) posted Cash & Equivalents of $3.88 billion for the quarter ended Sep 30, 2026, down 12.3% from $4.43 billion a year earlier and down 5.7% from the prior quarter.
Powered by 
Analysis
Gsk (GSK) Cash & Equivalents (2009 - 2026) Analysis & Trends
As of Dec 31, 2025, Gsk's Cash & Equivalents came in at $4.57 billion, down 5.8% from the prior year.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of -11.8% (years ended Dec 2020 to Dec 2025).
- In prior years, Gsk's Cash & Equivalents was $4.86 billion in the year ended Dec 31, 2024 (+29.9%), $3.74 billion in the year ended Dec 31, 2023 (-16.7%), $4.49 billion in the year ended Dec 31, 2022 (-22.2%) and $5.77 billion in the year ended Dec 31, 2021 (-32.7%).
- The figure for the quarter ended Sep 30, 2026 stands as the lowest quarterly Cash & Equivalents since the quarter ended Jun 30, 2024.
- On a year-over-year basis, Cash & Equivalents has declined in each of the last four quarters, with growth averaging 9.1% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was the quarter ended Mar 31, 2023, with growth of 613.3%; the weakest was the quarter ended Mar 31, 2022, with a decline of 92.3%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $4.12 billion (quarter ended Jun 30, 2026), $4.53 billion (quarter ended Mar 31, 2026) and $4.57 billion (quarter ended Dec 31, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 9.55 Bn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 400.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 1.82 Bn |
| 10 | Gsk | 102.08 Bn | 84.92 Bn | 8.73 Bn | 3.88 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.88 Bn |
| Jun 30, 2026 | 4.12 Bn |
| Mar 31, 2026 | 4.53 Bn |
| Dec 31, 2025 | 4.57 Bn |
| Sep 30, 2025 | 4.43 Bn |
| Jun 30, 2025 | 4.94 Bn |
| Mar 31, 2025 | 5.78 Bn |
| Dec 31, 2024 | 4.86 Bn |
| Sep 30, 2024 | 4.27 Bn |
| Jun 30, 2024 | 3.75 Bn |
| Mar 31, 2024 | 3.52 Bn |
| Dec 31, 2023 | 3.74 Bn |
| Sep 30, 2023 | 3.88 Bn |
| Jun 30, 2023 | 3.96 Bn |
| Mar 31, 2023 | 3.58 Bn |
| Dec 31, 2022 | 4.49 Bn |
| Sep 30, 2022 | 4.03 Bn |
| Jun 30, 2022 | 7.84 Bn |
| Mar 31, 2022 | 501.91 Mn |
| Dec 31, 2021 | 5.77 Bn |
API Access
Gsk Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GSK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "GSK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GSK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();